Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. - Wikidata - wikimedia - TriplyDB

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

http://www.wikidata.org/entity/Q33842520

about

Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patients The Alzheimer's Disease Neuroimaging Initiative informatics core: A decade in review Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans Clinical trial methodologies for disease-modifying therapeutic approaches The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception 18F-florbetaben Aβ imaging in mild cognitive impairment Imago Mundi, Imago AD, Imago ADNI The clinical value of large neuroimaging data sets in Alzheimer's disease Genome-wide association analysis of age-at-onset in Alzheimer's disease Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.Genome-wide association study of Alzheimer's disease Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease Imaging plus X: multimodal models of neurodegenerative disease.Advances in high-field magnetic resonance spectroscopy in Alzheimer's disease A data-driven model of biomarker changes in sporadic Alzheimer's disease.Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.A Novel Study Paradigm for Long-term Prevention Trials in Alzheimer Disease: The Placebo Group Simulation Approach (PGSA): Application to MCI data from the NACC database.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 Morphological and Microstructural Changes of the Hippocampus in Early MCI: A Study Utilizing the Alzheimer's Disease Neuroimaging Initiative Database.Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.Enhancing latent cognitive capacity in mild cognitive impairment with gist reasoning training: a pilot study Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.Quantitative structural MRI for early detection of Alzheimer's disease.Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairment.The growth and impact of Alzheimer disease centers as measured by social network analysis Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment.Identifying the neuroanatomical basis of cognitive impairment in Alzheimer's disease by correlation- and nonlinearity-aware sparse Bayesian learning.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Combined treatment with a BACE inhibitor and anti-Aβ antibody gantenerumab enhances amyloid reduction in APPLondon mice.An abnormal resting-state functional brain network indicates progression towards Alzheimer's disease.Aberrant hippocampal subregion networks associated with the classifications of aMCI subjects: a longitudinal resting-state study.Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions.Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.Communication Difficulty and Relevant Interventions in Mild Cognitive Impairment: Implications for Neuroplasticity.Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness.Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.Effects of multicomponent exercise on cognitive function in older adults with amnestic mild cognitive impairment: a randomized controlled trial Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

P2860

Q21559700-879A7023-24FA-4151-8ED0-5B68F40EA7EF Q26801637-96A53879-9B01-4C92-ADD6-E019A923469D Q26801657-1ADBDD4D-377B-4103-A8B1-733AC53C9B7B Q27001770-A9C118B9-8093-4938-B8CE-99070090B81A Q27006831-3E2A48A9-F5F1-4416-9E9B-E65C729C70FD Q27499311-268C281C-1217-4C32-85D0-4D6B67BAEAF1 Q28650395-B2397C5D-76B7-4970-B91B-E5E96E35293A Q28709465-F1804B97-D872-4B63-98BF-A1C0A6FA1A7D Q29417033-264797CA-52F4-4C28-9621-DF69A2315227 Q29417035-FBBF9A83-695D-4D54-8C28-06FF8B3777FC Q29417071-51008C36-AF2E-4C61-B6A3-97CE37ECA932 Q30354417-92E28959-4353-41AB-A65F-695A960D0F39 Q30354966-C2F82C37-E1F8-467A-BC14-E37BC9CBA99E Q30491715-4D6D2596-85B2-4F1B-90AB-541BED844279 Q30770751-9C0CB1A0-01DF-4491-9559-6A4E7E94B464 Q30835966-C277A76F-C465-4B3D-A806-598630AA9CA2 Q30845482-FF0CFCAA-5A98-4964-8D80-D001AA9C0757 Q30881418-C4D4C293-7312-428E-BDA2-B9D4C7301984 Q30971403-938504EA-FA19-4242-ABDF-BDCC855D008F Q30981669-3243B618-EE5D-4446-8FB4-6D5559B485F5 Q33567246-C473AB87-4FE2-4700-82E2-927790226C84 Q33575184-C9E188EF-4B57-42F4-AE9D-8D92ABAE28BD Q33626154-40CC1749-8458-440B-82E5-61041FBDBA8A Q33672569-1D7A9EEA-1DBD-42B3-B9F6-F35F0A0D2672 Q33729033-82486742-CA97-4457-953A-6897D96FF159 Q33895227-6F0DC400-D99C-49FD-9AFB-6503CAD7894E Q33895808-CEE7240E-7CD5-4F04-B92D-6FBB7FF8FAE2 Q33924292-31AFC842-CE4E-4DE4-BEB5-81129F1990DF Q33959979-CD8A92CE-A16F-475F-8E13-0DABF8D43E11 Q34065449-E6C392C2-E4F4-4C01-B108-8A4FE6035009 Q34091134-716DA792-4671-4597-B6EB-F85FF0EE3B60 Q34095084-21F55DFC-127F-4068-BA07-2A6A63C43C90 Q34117433-F064F39B-63D5-4106-A603-925E87B5FDD2 Q34318022-35424257-01CE-4FD0-B521-9FC8860FBBEA Q34333511-7E52127B-4A5E-4D99-A21D-DFAE560F5A2D Q34407243-52CF50CA-6401-49BD-B3FA-46F7D010A13E Q34432585-81DCF097-8B09-4522-9FA4-B508170D7F2D Q34462406-757F6A8A-3B6B-4CDA-AD38-0E657BC4743B Q34462642-F7569C19-58BE-4C6E-BAFA-FB833351382E Q34606557-9754FDA5-D2DB-406B-83FD-F2B50D6BFB54

P2860

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

http://www.wikidata.org/entity/Q33842520

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

@ast

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

@en

type

label

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

@ast

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

@en

prefLabel

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

@ast

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

@en

P1433

Q33842520-C4093583-CCCF-4672-868A-083EF3ED65E6

P1476

Q33842520-A3D2D5DA-0508-47BF-93D7-B0DCDBF06C8B

P2093

Q33842520-05B4612D-0440-4B61-8686-76B7CFA5BC81

Q33842520-369AB150-5D83-4554-8CA6-F02E2C8F3F49

Q33842520-D5BB31FA-A47E-42B9-8A9B-357F4B8B824D

Q33842520-E47E00E5-B2FB-41A9-BCCE-F3E9AECDE6E0

Q33842520-F000FDA9-D5DE-43FA-9B2B-1FB52F65EE3F

P2860

Q33842520-2DEFBCB6-0A47-4384-8079-EF97A5F41737

Q33842520-330E174D-C086-40DE-9BE9-D7FF9F411F38

Q33842520-4003CBFF-8476-41CA-9802-BB1DF115276E

Q33842520-6B3FFB61-81D4-4F12-8F04-9127FA389AFD

Q33842520-8DE8899A-F9BA-400F-8F46-93C8977B1538

Q33842520-90DDF912-E0F2-4E19-AC74-5CD7350B2F0D

Q33842520-B091EF0A-2422-4B19-A973-0FC1BE14B4C0

Q33842520-BB0E8B1C-F718-4EB7-A905-809F99740980

Q33842520-E86AAA6F-EDCF-43B1-9E61-45FCFA934E05

P304

Q33842520-FE2736EE-65F1-4B8B-A4B2-8380FEA81FCF

P31

Q33842520-36A5D170-EADA-493D-803C-E5C8771F24D6

P356

Q33842520-BE169D2E-F9C4-470E-937A-B6651F96D032

P433

Q33842520-C259DEC5-BA3B-4C2D-A1F7-054E87B279FB

P478

Q33842520-DA3F0334-92E3-4D57-B34A-2DD7A44CFE7B

P50

Q33842520-2E97D837-0150-4594-9F04-B6547A38E2F1

Q33842520-2F3181C5-D251-4372-9D99-FEC30F4C9085

Q33842520-2F9C8277-5A08-445C-A8EA-18AF0389B9AA

Q33842520-345C1072-2544-489D-846C-A8C06E265492

Q33842520-53B8F37D-B3AA-42FC-9D94-31F2B0E75EBA

Q33842520-75E4ACA4-6026-4E67-B12B-445910E5EF82

Q33842520-763ABE0B-59E7-4D61-B85A-4B50A3303E7E

Q33842520-7A945B54-B755-4C97-9964-BC2E7C1EFABC

Q33842520-7DF8ACF2-6274-4589-B0C3-461A6AF9CC49

Q33842520-B5ACF701-69C2-409A-B2AE-2142E6CDA649

P577

Q33842520-7D82C155-76AA-4244-91B5-CB84D83F5F04

P5875

Q33842520-13E586E9-6D44-40C7-AC23-2190BAC20B8C

P698

Q33842520-F9340441-9F49-4AEC-ACDB-D4BD7331A1BE

P921

Q33842520-36C3E51A-56F2-4DE9-B6EF-C88AE443F2F2

Q33842520-578D8A33-2D48-44FB-A7C6-E90FF548DE09

P932

Q33842520-AE8FEC3A-C9B8-439B-8838-718C4AE1FB9A

P356

J.JALZ.2010.03.006

P1433

Alzheimer's and Dementia

P1476

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

@en

P2093

Anthony Gamst

http://www.w3.org/2001/XMLSchema#string

Leslie M Shaw

http://www.w3.org/2001/XMLSchema#string

Rema Raman

http://www.w3.org/2001/XMLSchema#string

Ronald G Thomas

http://www.w3.org/2001/XMLSchema#string

Sarah Walter

http://www.w3.org/2001/XMLSchema#string

P2860

Recent developments in Alzheimer's disease therapeutics

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

The measurement of everyday cognition (ECog): scale development and psychometric properties.

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Mild cognitive impairment: ten years later.

Alzheimer's disease: progress in prediction.

Alzheimer's disease therapeutic research: the path forward

P304

239-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JALZ.2010.03.006

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Andrew J. Saykin

Michael Donohue

Alzheimer's Disease Neuroimaging Initiative

Ronald C. Petersen

Michael W. Weiner

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44581958

http://www.w3.org/2001/XMLSchema#string

P698

20451872

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's Disease Neuroimaging Initiative

P932

2867843

http://www.w3.org/2001/XMLSchema#string